Objective To summarize and analyze the clinical effect of Yinjia Pill(adjusted according to symptoms)combined with azithromycin on female genital tract mycoplasma infection(damp-heat stasis type).Methods From September 2019 to September 2021,40 female patients with genital tract mycoplasma infection(damp-heat stasis type)admitted to the inpatient department of our department were selected as the observation group,and were treated with Yinjia Pill and Azithromycin.Another 40 patients admitted in the same period were included in the control group and treated with azithromycin alone.The mycoplasma negative conversion rate,adverse reaction rate,TCM syndrome score and clinical curative effect of the two groups were observed and compared.Results ① The negative conversion rate of UU in observation group was 92.5％higher than that in control group(80.00％,P＜0.05);the incidence of adverse effects was 10％for the observation cohort and 8％for the control,showing no significant disparity between them(P＞0.05).② Prior to therapy,both groups exhibited comparable TCM syndrome scores(P＞0.05).After treatment,the scores of TCM syndromes of the patients in the two groups decreased compared with those before treatment,and there was a difference(P＜0.05).Post-treatment,the observation group showed notably reduced TCM syndrome scores compared to the control group(P＜0.01).(3)The total effective rate of clinical treatment of 40 patients in the observation group was 85％,which was higher than 75％in the control group(P＜0.05).Conclusion Azithromycin combined with Chinese medicine Yinjia Pill(adjusted according to symptoms)has shown outstanding effects in female genital tract mycoplasma infection.The synergistic effects of the two treatments are significant,providing a new effective treatment option for this disease.It is worth promoting and applying in clinical practice.
Yinjia PillAzithromycinMycoplasma InfectionDamp-heat Stasis Type
维普
万方数据
